Ha Tay Pharmaceutical JSC (HNX:DHT)

Vietnam flag Vietnam · Delayed Price · Currency is VND
75,600
+100 (0.13%)
At close: Dec 5, 2025
-20.65%
Market Cap 6.85T
Revenue (ttm) 2.25T
Net Income (ttm) 66.57B
Shares Out 90.57M
EPS (ttm) 734.97
PE Ratio 102.86
Forward PE n/a
Dividend 909.09 (1.20%)
Ex-Dividend Date n/a
Volume 10,381
Average Volume 11,540
Open 75,500
Previous Close 75,500
Day's Range 73,000 - 77,000
52-Week Range 69,000 - 95,455
Beta 0.22
RSI 51.75
Earnings Date Jan 22, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam. [Read more]

Industry Pharmaceutical Preparations
Founded 1965
Country Vietnam
Stock Exchange Hanoi Stock Exchange
Ticker Symbol DHT
Full Company Profile

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.

Financial Statements

News

There is no news available yet.